Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 60% ± 14% | |
lung | 18 studies | 44% ± 16% | |
intestine | 12 studies | 39% ± 16% | |
kidney | 8 studies | 40% ± 15% | |
eye | 6 studies | 31% ± 17% | |
lymph node | 6 studies | 48% ± 16% | |
liver | 6 studies | 37% ± 18% | |
brain | 6 studies | 29% ± 7% | |
bone marrow | 5 studies | 43% ± 23% | |
pancreas | 4 studies | 50% ± 6% | |
placenta | 4 studies | 49% ± 23% | |
uterus | 4 studies | 58% ± 9% | |
adipose | 4 studies | 29% ± 11% | |
breast | 4 studies | 58% ± 11% | |
adrenal gland | 3 studies | 36% ± 15% | |
esophagus | 3 studies | 44% ± 30% | |
thymus | 3 studies | 63% ± 33% | |
prostate | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 20163.76 | 459 / 459 | 100% | 165.95 | 1118 / 1118 |
uterus | 100% | 11134.43 | 170 / 170 | 100% | 99.80 | 459 / 459 |
skin | 100% | 18827.43 | 1809 / 1809 | 100% | 162.69 | 471 / 472 |
lung | 100% | 14302.59 | 577 / 578 | 100% | 121.57 | 1153 / 1155 |
bladder | 100% | 10010.52 | 21 / 21 | 100% | 127.47 | 502 / 504 |
pancreas | 99% | 11099.09 | 326 / 328 | 100% | 120.79 | 178 / 178 |
thymus | 100% | 11066.26 | 651 / 653 | 100% | 112.73 | 603 / 605 |
adrenal gland | 100% | 12799.77 | 258 / 258 | 99% | 109.30 | 228 / 230 |
intestine | 100% | 10508.51 | 962 / 966 | 99% | 143.68 | 524 / 527 |
prostate | 100% | 9674.03 | 244 / 245 | 99% | 102.44 | 499 / 502 |
esophagus | 99% | 11470.58 | 1437 / 1445 | 99% | 72.08 | 182 / 183 |
stomach | 100% | 8841.80 | 358 / 359 | 99% | 111.53 | 283 / 286 |
kidney | 99% | 9172.63 | 88 / 89 | 99% | 105.93 | 893 / 901 |
ovary | 100% | 10986.01 | 180 / 180 | 96% | 61.16 | 413 / 430 |
brain | 76% | 3668.95 | 2010 / 2642 | 100% | 89.21 | 704 / 705 |
liver | 83% | 4250.66 | 187 / 226 | 93% | 66.52 | 378 / 406 |
adipose | 100% | 21089.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 150.26 | 29 / 29 |
spleen | 100% | 14174.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 119.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 43.26 | 1 / 1 |
blood vessel | 99% | 14644.72 | 1324 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 155.62 | 79 / 80 |
muscle | 94% | 7158.42 | 753 / 803 | 0% | 0 | 0 / 0 |
heart | 92% | 6792.93 | 796 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 7809.20 | 805 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048026 | Biological process | positive regulation of mRNA splicing, via spliceosome |
GO_0006417 | Biological process | regulation of translation |
GO_0045727 | Biological process | positive regulation of translation |
GO_0006396 | Biological process | RNA processing |
GO_0015934 | Cellular component | large ribosomal subunit |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0043023 | Molecular function | ribosomal large subunit binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | RBM3 |
Protein name | RNA-binding protein 3 (RNA-binding motif protein 3) (RNPL) LP5581 (RNA binding motif (RNP1, RRM) protein 3, isoform CRA_a) RNA binding motif (RNP1, RRM) protein 3, isoform CRA_b (RNA binding motif protein 3) (cDNA: FLJ23011 fis, clone LNG00572) |
Synonyms | RNPL hCG_19813 |
Description | FUNCTION: Cold-inducible mRNA binding protein that enhances global protein synthesis at both physiological and mild hypothermic temperatures. Reduces the relative abundance of microRNAs, when overexpressed. Enhances phosphorylation of translation initiation factors and active polysome formation (By similarity). . |
Accessions | ENST00000354480.2 Q6XYB6 Q9H5V0 ENST00000376755.1 ENST00000376759.8 P98179 |